Avery Dennison Corporation has announced that it has achieved another market first with the technology approval from ...

("NeurAxis,” or the "Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...

The three federal agencies wrote that “important scientific gaps exist” when it comes to understanding ... Mead Johnson ...

Vazalore is currently the only FDA-approved human aspirin that may be used in food-producing animals under certain conditions ...

announced today that its industry-leading LabTAG laboratory labels are now fully compatible with eLabNext’s Digital Laboratory Platform. The strategic partnership provides the scientific ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

Final data from these trials will be submitted to the Food and Drug Administration to support a label expansion to include these patient ... at risk from RSV disease,” said Tony Wood, Chief Scientific ...

There are some clear instances of generative-AI use in scientific images, such as the now-infamous figure of a rat with ...

Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.

The label expansion adds to the existing label ... stating its intention to publish these in a peer-reviewed scientific ...

and is eyeing a label expansion in the second half of 2025. And late last year, Boston Scientific launched a trial to explore pulsed field ablation as a first-line therapy, in a new potential ...

Earlier this year, cheese fans panicked following the publication of new research on essential cheesemaking moulds, certain ...